Kapil Kumar, B. Nearing, Carlo R. Bartoli
Oct 1, 2008
Citations
0
Influential Citations
36
Citations
Journal
Journal of Cardiovascular Electrophysiology
Abstract
Introduction: Extensive in vitro studies and clinical evidence (MERLIN trial) indicate an antiarrhythmic potential of ranolazine, a novel antianginal agent. Programmed electrophysiologic testing was performed to quantify ranolazine's effects on ventricular vulnerability and defibrillation thresholds and to gain insights into mechanisms.